Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Butterly, Elaine
54  Ergebnisse:
Personensuche X
?
1

Description of subgroup reporting in clinical trials of chr..:

Wei, Lili ; Butterly, Elaine ; Rodríguez Pérez, Jesús...
BMJ Open.  14 (2024)  6 - p. e081315 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Assessing trial representativeness using serious adverse ev..:

Hanlon, Peter ; Butterly, Elaine ; Shah, Anoop S. V....
BMC Medicine.  20 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
3

Calibrating a network meta-analysis of diabetes trials of s..:

Butterly, Elaine ; Wei, Lili ; Adler, Amanda I...
BMJ Open.  12 (2022)  10 - p. e066491 , 2022
Link: https://doi.org/10.1136/..
 
?
4

An analysis of frailty and multimorbidity in 20,566 UK Biob..:

Hanlon, Peter ; Jani, Bhautesh D. ; Butterly, Elaine...
Communications Medicine.  1 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
5

Identifying frailty in trials: an analysis of individual pa..:

Hanlon, Peter ; Butterly, Elaine ; Lewsey, Jim...
BMC Medicine.  18 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
6

Frailty measurement, prevalence, incidence, and clinical im..:

Hanlon, Peter ; Fauré, Isabella ; Corcoran, Neave...
The Lancet Healthy Longevity.  1 (2020)  3 - p. e106-e116 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Identification and prevalence of frailty in diabetes mellit..:

Hanlon, Peter ; Fauré, Isabella ; Corcoran, Neave...
BMJ Open.  10 (2020)  9 - p. e037476 , 2020
Link: https://doi.org/10.1136/..
 
?
8

Participant characteristics and exclusion from phase 3/4 in..:

Lees, Jennifer ; Crowther, Jamie ; Hanlon, Peter...
BMJ Medicine.  3 (2024)  1 - p. e000732 , 2024
Link: https://doi.org/10.1136/..
 
?
9

Comorbidity and health-related quality of life in people wi..:

Butterly, Elaine W. ; Hanlon, Peter ; Shah, Anoop S. V....
PLOS Medicine.  20 (2023)  1 - p. e1004154 , 2023
Link: https://doi.org/10.1371/..
 
?
10

Correlations between comorbidities in trials and the commun..:

Crowther, Jamie ; Butterly, Elaine W ; Hannigan, Laurie J...
Journal of Multimorbidity and Comorbidity.  13 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
11

Treatment effect modification due to comorbidity: Individua..:

Hanlon, Peter ; Butterly, Elaine W. ; Shah, Anoop SV...
PLOS Medicine.  20 (2023)  6 - p. e1004176 , 2023
Link: https://doi.org/10.1371/..
 
?
12

Effect of age, sex, and morbidity count on trial attrition:..:

Lees, Jennifer S ; Hanlon, Peter ; Butterly, Elaine W...
BMJ Medicine.  1 (2022)  1 - p. e000217 , 2022
Link: https://doi.org/10.1136/..
 
?
13

Improving the Estimation of Subgroup Effects for Clinical T..:

Hannigan, Laurie J. ; Phillippo, David M. ; Hanlon, Peter...
Medical Decision Making.  42 (2021)  2 - p. 228-240 , 2021
Link: https://doi.org/10.1177/..
 
?
14

ITCA 650:

Butterly, Elaine W
Practical Diabetes.  35 (2018)  2 - p. 69-70 , 2018
Link: https://doi.org/10.1002/..
 
?
15

Treatment effect modification due to comorbidity: individua..:

Hanlon, Peter ; Butterly, Elaine ; Shah, Anoop S.V...
https://eprints.gla.ac.uk/298260/1/298260.pdf.  , 2023
Link: https://eprints.gla.ac.u..
 
1-15